PharmaDrug Advances DMT-Analogue Program for Glaucoma with Production of Medical Device Designed to Provide Sustained Control of Elevated Intraocular Pressure
Ryan Allway April 7th, 2022 Psychedelics, Top News Prototype medical device engineered to deliver sustained, sub-psychedelic quantities of candidate DMT-analogues In vitro, time dependent drug elution profile evaluated for three candidate molecules Biocompatibility of drug-loaded medical device demonstrates cell-based safety at doses anticipated to be within therapeutic range Current... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )